Corrigendum: The effect of azoximer bromide (Polyoxidonium(®)) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

The authors wish to make the following corrections to their article: Efimov SV, Matsiyeuskaya NV, Boytsova OV, et al. Corrigendum: The effect of azoximer bromide (Polyoxidonium(®)) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232657/
https://www.ncbi.nlm.nih.gov/pubmed/34234832
http://dx.doi.org/10.7573/dic.2021-5-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232657/
https://www.ncbi.nlm.nih.gov/pubmed/34234832
http://dx.doi.org/10.7573/dic.2021-5-2

Ejemplares similares